01 / DESIGN
What was studied?
Transgenic mice were assessed with behavioral tasks and brain histology after exposure to Semax or a derivative.
02 / FINDINGS
What did the researchers report?
The study reported better selected behavioral performance and fewer amyloid inclusions in examined brain regions.
03 / LIMITS
How should it be interpreted?
An amyloid-model result is not demonstrated treatment of human Alzheimer's disease. The derivative is a separate material, and the abstract does not establish comprehensive safety.
Voltera Peptide editorial reading note. Based on the linked source record. Methods and corrections.